Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Emergence of OXA-48 beta-lactamase in Enterobacteriaceae in Croatia (CROSBI ID 634115)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Varda-Brkić, Dijana ; Beader, Nataša ; Čačić, Marko ; Vranić-Ladavac, Mirna ; Sardelić, Sanda ; Jajić, Ines ; Grisold, Andrea ; Zarfel, Gernot ; Luxner, Josefa ; Bošnjak, Zrinka et al. Emergence of OXA-48 beta-lactamase in Enterobacteriaceae in Croatia // P0749. 2016

Podaci o odgovornosti

Varda-Brkić, Dijana ; Beader, Nataša ; Čačić, Marko ; Vranić-Ladavac, Mirna ; Sardelić, Sanda ; Jajić, Ines ; Grisold, Andrea ; Zarfel, Gernot ; Luxner, Josefa ; Bošnjak, Zrinka ; Bedenić, Branka

engleski

Emergence of OXA-48 beta-lactamase in Enterobacteriaceae in Croatia

Background : Previous studies found VIM-1, NDM- 1 and KPC-2 among CRE in Croatia with VIM-1 being the most prevalent. Recently OXA-48 was identified in three hospital centers. Material and methods: Since 2012 surveillance system for CRE was implemented in University Hospital Center (UHZ) in Croatia which inluded phenotypic and molecular identification of carbapenemases in Enterobacteriaceae. In total four carbapenem non-susceptible strains of K. pneumoniae were found to be positive for OXA-48 in three hospital centers (University Hospital Center Zagreb-UHZ, University Hospital Center Sisters of Mercy-UHM, University Hospital Split-UHS). The antimicrobial susceptibility was determined by broth microdilution method. Double-disk-synergy test (DDST) was performed to detect ESBLs and modified Hodge test (MHT) was used to screen for production of carbapenemases. MBL E-test was used to screen for metallo-β-lactamases (MBLs). Additionally the isolates were tested by combined disks test with EDTA or 3-aminophenylboronic to screen for KPC, MBLs or simoultaneous production of MBL and KPC respectively. The transferability of meropenem resistance was determined by conjugation employing E. coli A15R- strain resistant to sodium-azide. The presence of genes encoding broad and extended-spectrum β- lactamases (blaSHV, blaTEM, blaCTX-M and blaPER-1), plasmid-mediated AmpC β-lactamases, group A carbapenemases (blaKPC, blaSME, blaIMI, blaNDM), metallo β-lactamases (blaVIM, blaIMP and blaNDM), and carbapenem hydrolyzing oxacillinases (blaOXA-48), was determined by PCR. Results: The strains were uniformly resistant to amoxicillin alone and combined with clavulanate, cefazoline, cefuroxime, ceftazidime, cefotaxime, ceftriaxone, but uniformly susceptible to colistin and had variable resistance patterns to carbapenems. Modified Hodge test was positive indicating the production of carbapenemase. Phenotypic testing was positive for ESBL but negative for, MBL, KPC and AmpC. Meropenem resistance was not transferred to E. coli recipient strain. PCR revealed the strains to be positive also for CTX-M-15 and TEM-1. The strains from UHC coproduced OXA-48 and VIM-1. Two strains from UHZ had identical rep-PCR patterns but different from those from UHS and UHM. The patients did not have a travel history to the countries where OXA-48 is endemic. Conclusions The study demonstrated emergence of OXA-48 β- lactamase in three hospital centers located in different geographic regions in Croatia The strains from different hospitals displayed different rep_PCR patterns and thus it could be concluded that they occurred as independent events. OXA-48 was first report in Turkey in 2001 but later spread in Mediterranean and western European countries such as Israel, France, Italy, Spain, Germany, Switzerland, Belgium and the Netherlands. . Most of the strains in western Europe were imported from Turkey, Morocco, Egypt, Algeria or Lybia. Croatia was spared from this type of carbapenemas until 2014. In our study there was no link to the endemic areas.

OXA-48; Klebsiella pneumoniae; resistance; carbapenems

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

2016.

objavljeno

Podaci o matičnoj publikaciji

Podaci o skupu

26th European congress of Clinical Microbiology and Infectious Diseases

poster

09.04.2016-12.04.2016

Amsterdam, Nizozemska

Povezanost rada

Temeljne medicinske znanosti